intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,63,200,38,397,2,700
questionnaire,10,47,3,52,1,113
no intervention,3,14,5,43,0,65
blood sample,3,6,1,26,0,36
pcr,2,13,2,13,0,30
online survey,1,8,2,7,0,18
serology test,2,5,2,8,0,17
vaccine,2,0,1,13,0,16
observational,0,4,0,10,1,15
biological samples,1,1,0,10,0,12
covid-19,1,2,0,7,1,11
saliva,2,2,1,6,0,11
lung ultrasound,2,2,1,4,1,10
survey,2,7,0,1,0,10
data collection,0,3,0,6,0,9
prone positioning,2,6,0,1,0,9
exposure,1,3,0,4,0,8
observation,0,3,0,5,0,8
ct-scan,1,2,0,4,0,7
remdesivir,0,1,0,6,0,7
standard care,0,2,0,5,0,7
biospecimen collection,0,0,0,6,0,6
blood test,2,0,0,4,0,6
exercise,0,0,1,5,0,6
igm/igg rapid test,0,3,2,1,0,6
interview,1,3,0,2,0,6
ace inhibitor,0,3,0,2,0,5
clinical assessment,0,3,0,2,0,5
convalescent plasma,2,1,0,2,0,5
covid-19 pandemic,1,2,0,2,0,5
data,2,2,0,1,0,5
hydroxychloroquine,2,3,0,0,0,5
igg antibody test,0,2,2,1,0,5
quality-of-life assessment,0,0,0,5,0,5
serum test,0,2,0,3,0,5
ultrasound,0,3,0,2,0,5
echocardiography,0,3,0,1,0,4
electronic health record review,0,0,0,4,0,4
igm,0,1,1,2,0,4
ivermectin,0,4,0,0,0,4
nasopharyngeal swab,0,3,0,1,0,4
other,0,2,0,2,0,4
quality of life,0,1,1,2,0,4
tocilizumab,0,0,0,4,0,4
arb,0,1,0,2,0,3
bnt162b2,0,0,0,3,0,3
bronchoalveolar lavage,1,0,0,2,0,3
data record,0,0,0,3,0,3
ecg,0,0,0,3,0,3
flow cytometry,0,2,0,1,0,3
igg,0,1,1,1,0,3
interleukin,1,0,0,2,0,3
methylprednisolone,0,2,0,1,0,3
non-interventional,0,1,0,2,0,3
spirometry,0,0,1,2,0,3
taste,0,2,0,1,0,3
a questionnaire,0,1,0,1,0,2
acute kidney injury,0,1,0,1,0,2
appendectomy,0,2,0,0,0,2
assessment of work-related stress,1,1,0,0,0,2
autopsy,0,1,0,1,0,2
azithromycin,1,1,0,0,0,2
behavior,0,1,1,0,0,2
bnt162b2 mrna covid-19 vaccine,0,0,0,2,0,2
breath biopsy,0,2,0,0,0,2
breath biopsy face masks with removable filters/fitted pva strip,0,2,0,0,0,2
breath test,0,0,0,2,0,2
brescä°a-covä°d respiratory severity scale,0,2,0,0,0,2
cardiac,1,1,0,0,0,2
cardiac/electrodermal recordings,1,1,0,0,0,2
chest computed tomography,0,1,0,1,0,2
chest ct,0,2,0,0,0,2
clinical data,2,0,0,0,0,2
clinical features,0,1,0,1,0,2
corticosteroid,1,0,0,1,0,2
covid-19 infection,0,1,0,0,1,2
covid-19 vaccination,0,0,0,2,0,2
covid-19/ observational,0,0,0,1,1,2
dalteparin,0,2,0,0,0,2
data collection/clinical testing of subjects,0,1,0,1,0,2
diagnostic laboratory biomarker analysis,0,0,0,2,0,2
diagnostic test,0,1,0,1,0,2
dialysis,1,0,0,1,0,2
electrodermal recordings,1,1,0,0,0,2
elisa,0,2,0,0,0,2
emotional stimulation,1,1,0,0,0,2
favipiravir,1,0,0,1,0,2
fear of covid-19 scale,0,1,0,1,0,2
file scanning,0,1,0,1,0,2
fitted pva strip,0,2,0,0,0,2
"ib10 sphingotestâ® bio-admâ® apparatus (sphingotec gmbh, hennigsdorf, germany)",0,0,0,2,0,2
igm antibodytest,0,2,0,0,0,2
impulseâ„¢ una e-stethoscope,0,2,0,0,0,2
impulseâ„¢ una infrasound-to-ultrasound e-stethoscope,0,0,0,2,0,2
indicators of central sensitisation,0,0,0,2,0,2
ion mobility spectrometry (ims),0,2,0,0,0,2
lung ultrasound (lus),0,0,0,2,0,2
mask,0,1,0,0,1,2
mri,0,0,0,2,0,2
nanomix elabâ® covid-19 rapid antigen panel (non-interventional),0,0,0,2,0,2
nasal,0,1,0,1,0,2
non,0,1,1,0,0,2
non interventional study,0,0,0,2,0,2
oxygen,0,0,0,2,0,2
patient-reported online questionnaire on olfactory,0,1,0,1,0,2
patient-reported online questionnaire on olfactory/taste disturbances,0,1,0,1,0,2
phone call interview,0,1,0,1,0,2
poc covidxâ„¢ rapid antigen test,0,2,0,0,0,2
practice details,0,2,0,0,0,2
pulmonary function tests,0,0,0,2,0,2
pulmonary rehabilitation,1,1,0,0,0,2
rapid test,0,2,0,0,0,2
retrospective data collection,0,0,0,2,0,2
rothâ´s test,0,2,0,0,0,2
saliva sampling,0,1,0,1,0,2
sample collection,2,0,0,0,0,2
sampling,0,0,0,2,0,2
sars-cov-2,0,1,0,1,0,2
sars-cov2 testing,0,1,0,1,0,2
semen analysis,0,1,0,1,0,2
semi-directive interview,0,0,0,2,0,2
surgery,0,1,0,1,0,2
t-detectâ„¢ sars-cov-2 assay,0,2,0,0,0,2
taste disturbances,0,1,0,1,0,2
teleconsultation,1,0,0,1,0,2
telehealth,0,1,1,0,0,2
test,0,0,0,2,0,2
throat swab,0,1,0,1,0,2
tinzaparin,0,2,0,0,0,2
tinzaparin/dalteparin,0,2,0,0,0,2
ultrasonography,0,1,0,1,0,2
vitamin d,0,1,0,1,0,2
whole exome sequencing,0,0,0,2,0,2
,0,0,0,1,0,1
(ppa >95%) fda eua rt-pcr,0,0,0,1,0,1
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,1,0,0,0,1
[11c]sl25.1188 pet scan,0,0,0,1,0,1
[18f]feppa pet scan,0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet,0,1,0,0,0,1
[68ga]ga-dota-(rgd)2 pet/ct,0,1,0,0,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
10 to 14 days later,0,0,0,1,0,1
2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,0,0,0,1,0,1
25 oh vitamin d level,0,1,0,0,0,1
25 post icu-patients,0,0,0,1,0,1
25 post non-icu patients,0,0,0,1,0,1
40-steps-test,0,0,0,1,0,1
40ml blood sample,0,0,1,0,0,1
6 minute walk test,0,0,1,0,0,1
6 weeks after delivery,0,1,0,0,0,1
a - samples collected along routine care samples only,0,0,0,1,0,1
a questionnaire/scales,0,0,0,1,0,1
a questionnaire/scales.,0,1,0,0,0,1
a survey form was applied to individuals included in the study face-to-face.,0,1,0,0,0,1
a survey of 60 questions was created through the internet-based 'google forms surveys' site.,0,1,0,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
aat( alpha 1 antitrypsin),0,1,0,0,0,1
abpm,0,0,0,1,0,1
ace inhibitor/arb,0,1,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
active covid-19 disease,0,0,0,1,0,1
activity,0,1,0,0,0,1
adam sensor,0,0,0,1,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
additional,0,0,0,1,0,1
additional/minimal collection of products of the human body carried out during a sample for standard of care,0,0,0,1,0,1
adjunctive therapies,1,0,0,0,0,1
admission to icu for covid-19,0,1,0,0,0,1
aerosol box,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ai model,1,0,0,0,0,1
airwave oscillometry,0,0,0,1,0,1
airway pressure release ventilation,0,1,0,0,0,1
albuterol sulfate (mdi),0,0,0,1,0,1
albuterol sulfate (nebulizer),0,0,0,1,0,1
alexa amazon,0,0,0,1,0,1
algorithm,1,0,0,0,0,1
all treatment about covid-2019,0,0,0,1,0,1
alternate nostril breathing,0,1,0,0,0,1
alternative medicine,0,1,0,0,0,1
amh sampling,0,0,0,1,0,1
aminoterminal type iii peptide of procollagen,1,0,0,0,0,1
anakinra,0,1,0,0,0,1
analog scale,0,0,0,1,0,1
analysis of blood samples,0,0,0,1,0,1
analysis of cell-mediated,0,0,0,1,0,1
analysis of cell-mediated/antibody-mediated immunity to sars-cov-2 virus,0,0,0,1,0,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
anesthesia management,0,1,0,0,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
anne one,0,0,1,0,0,1
anti-covid test,1,0,0,0,0,1
anti-sars-cov-2 antibody testing,0,0,0,1,0,1
anti-sars-cov2 serological controls,0,1,0,0,0,1
anti-sars-cov2 serological controls/serum neutralization,0,1,0,0,0,1
anti-spike sars-cov-2 igg,0,0,0,1,0,1
anti covid19 igg antibodies,0,0,0,1,0,1
antibiotic,1,0,0,0,0,1
antibodies testing,0,1,0,0,0,1
antibody-mediated immunity to sars-cov-2 virus,0,0,0,1,0,1
antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,0,0,0,1,0,1
antibody tests,0,0,0,1,0,1
"antibody tests,",1,0,0,0,0,1
antidiabetic treatment,0,1,0,0,0,1
antigen,1,0,0,0,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombin iii,0,0,0,1,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
anxiety,0,0,0,1,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety),0,0,1,0,0,1
anxiety/depression assessment,0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
apixaban,0,0,0,1,0,1
apple watch,0,0,0,1,0,1
approved vaccines against sars-cov2,0,0,0,1,0,1
arb blocker,0,1,0,0,0,1
arterial blood gas,0,0,0,1,0,1
arterial blood gas (abg),1,0,0,0,0,1
arterial line,0,0,0,1,0,1
assessing the impact of covid-19,0,1,0,0,0,1
assessment of lung mechanics,0,0,0,1,0,1
assessment of lung mechanics/heart-lung interactions,0,0,0,1,0,1
assessment of mental state,0,1,0,0,0,1
assessment of mental state/quality of life,0,1,0,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,1,0,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,1,0,0,0,1
assessment of proinflammatory cytokine production,0,0,0,1,0,1
assessment of proinflammatory cytokine production/immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),0,0,0,1,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment of ventilator-associated pneumonia criteria,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
attendance by ambulance crew,0,0,0,1,0,1
audio-visual triage system (avt),0,1,0,0,0,1
auscul-x,0,0,0,1,0,1
autoimmunity,0,1,0,0,0,1
autologous stem cell transplantation,0,0,0,1,0,1
awake prone position,0,1,0,0,0,1
axillary sweat sample,0,0,0,1,0,1
ayurvedic kadha,0,1,0,0,0,1
azd1222,0,0,0,1,0,1
background questionnaire,0,0,0,1,0,1
balance assessments,0,0,0,1,0,1
bariatric procedures,0,0,0,1,0,1
baricitinib,0,1,0,0,0,1
baricitinib/anakinra,0,1,0,0,0,1
bbibp-corv,0,0,0,1,0,1
bbv152,0,0,0,1,0,1
bd lyotubes,0,1,0,0,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behavioral/cognitive assessment,0,0,1,0,0,1
beta interferon,0,0,0,1,0,1
big five inventory (bfi) scale,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological check-up data collect,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biomarkers of inflammation,1,0,0,0,0,1
biosensor,0,0,0,1,0,1
blood coagulation profile,0,1,0,0,0,1
"blood collection at day 8, day 16, day 24, month 6",0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6/month 12 after first symptoms from sars-cov-2 infection",0,0,0,1,0,1
blood sampling (venesection),0,0,0,1,0,1
blood serum samples,0,1,0,0,0,1
blood test for sars-cov2 serology,0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
bloodwork,0,0,0,1,0,1
bnt162b2 vaccine,0,0,0,1,0,1
bovhyaluronidase azoxymer,0,0,0,1,0,1
breast feeding adherence,0,0,0,1,0,1
brief cope scale,0,0,0,1,0,1
bronchial fibroscopy,0,0,0,1,0,1
brushing,0,0,0,1,0,1
burnout,0,0,0,1,0,1
butterfly,0,0,0,1,0,1
bva-100,0,0,0,1,0,1
by computer consultation,0,1,0,0,0,1
c-reactive protein,0,0,0,1,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
cambridge validated viral detection,0,0,0,1,0,1
capnography,0,0,0,1,0,1
cardiac ct,0,0,0,1,0,1
cardiac mri,0,0,0,1,0,1
cardiac surgery,0,0,0,1,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary exercise test,0,0,0,1,0,1
cardiopulmonary fitness level,0,0,0,1,0,1
cardiopulmonary stress test (cpet),0,0,0,1,0,1
cardiovascular,0,0,0,1,0,1
cardiovascular/respiratory systems monitoring,0,0,0,1,0,1
care modalities,0,1,0,0,0,1
carotid artery reactivity testing,1,0,0,0,0,1
case fatality rate,0,1,0,0,0,1
cbc-diff monocyte volume width distribution,0,0,0,1,0,1
cellular,0,0,0,1,0,1
cellular immune response after anti-sars-cov-2 vaccine administration,0,0,0,1,0,1
cellular immunity,0,0,1,0,0,1
cellular response,0,1,0,0,0,1
cellular/antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,0,0,0,1,0,1
change in kidney function,0,1,0,0,0,1
change in kidney function/proteinuria,0,1,0,0,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
chart review,0,0,0,1,0,1
chelsea critical care physical assessment tool,0,0,0,1,0,1
chemotherapy,1,0,0,0,0,1
chest mri,0,0,0,1,0,1
chest radiography,0,0,1,0,0,1
chiropractic care,1,0,0,0,0,1
chitotriosidase activity,1,0,0,0,0,1
chlorine dioxide,0,0,0,1,0,1
clinical,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical examination,0,0,0,1,0,1
clinical features/laboratory values,0,1,0,0,0,1
clinical interview,1,0,0,0,0,1
clinical observation,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
"clinical, functional",0,0,0,1,0,1
"clinical, functional/radiological lung involvement evolution",0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinical/functional analysis,0,0,0,1,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
clungene rapid test cassette,0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,0,0,0,1,0,1
cobicistat,0,0,0,1,0,1
coca is an observational study based on retrospective data issued from patient medial file.,0,1,0,0,0,1
cognitive assessment,0,0,1,0,0,1
cognitive testing,0,0,0,1,0,1
cognitive tests,0,0,0,1,0,1
collection of breath sample,0,0,0,1,0,1
collection of clinical events of interest,0,1,0,0,0,1
collection of mucosal lining fluid,0,1,0,0,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
colorectal resections,1,0,0,0,0,1
comet assay,0,0,0,1,0,1
communication,0,1,0,0,0,1
communication during the covid-19 pandemic,0,0,0,1,0,1
community-driven messages to promote covid-19 testing,0,1,0,0,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
comparison of antigen tests with rt-pcr as reference method,0,0,0,1,0,1
comparison of cohorts,0,1,0,0,0,1
complementary,0,1,0,0,0,1
complementary/alternative medicine,0,1,0,0,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
completion of post telemedicine encounter survey,0,1,0,0,0,1
completion of pre-pandemic survey,0,1,0,0,0,1
completion of survey after peak of pandemic,0,1,0,0,0,1
comprehensive treatment,0,0,0,1,0,1
confinement,0,0,0,1,0,1
confinement/communication during the covid-19 pandemic,0,0,0,1,0,1
connected devices measurements,0,1,0,0,0,1
continuous positive airway pressure (cpap) treatment,0,1,0,0,0,1
continuous renal replacement therapy,0,0,0,1,0,1
contrast-enhanced mri,0,0,0,1,0,1
control,0,0,0,1,0,1
control group quality of life assessment,0,1,0,0,0,1
control treatment schedule,0,0,0,1,0,1
"copper, vitamin a, d, e plasma concentrations during patient hospitalization",0,1,0,0,0,1
coronacheck device,0,0,0,1,0,1
coronary angiography,0,1,0,0,0,1
coronavac,0,0,0,1,0,1
coronavac vaccine,0,0,0,1,0,1
corticosteroid alone,0,0,0,1,0,1
corticosteroid with,0,1,0,0,0,1
corticosteroid with/without colchicine,0,1,0,0,0,1
corticosteroids/derivatives,1,0,0,0,0,1
cov-scan rapid covid-19 antigen test,0,0,0,1,0,1
coviage,0,1,0,0,0,1
covicu,0,0,0,1,0,1
covid-19 / patients,1,0,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
"covid-19 antigen/antibody tests,/influenza rapid test",1,0,0,0,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 group,0,0,0,1,0,1
covid-19 group (group i),0,0,0,1,0,1
covid-19 group (group ii),0,0,0,1,0,1
"covid-19 inactive vaccine, recombinant human adenovirus serotype number 26, mrna vaccine",0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
covid-19 monitoring using wearable sensors,1,0,0,0,0,1
covid-19 monitoring using wearable sensors/smartphone technology,1,0,0,0,0,1
covid-19 nasal,1,0,0,0,0,1
covid-19 nasal/pharyngeal swab,1,0,0,0,0,1
covid-19 pcr swab,0,0,0,1,0,1
covid-19 pneumonia,0,0,0,1,0,1
covid-19 positive,0,0,0,1,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 presto test,0,0,0,1,0,1
covid-19 serology igg,0,0,0,1,0,1
covid-19 survey,0,0,1,0,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19 vaccine hesitancy associated factors,0,0,0,1,0,1
covid-19 vaccine hesitancy scale in rheumatic diseases,0,0,0,1,0,1
covid-19/intensive care,0,1,0,0,0,1
covid-antibody test,1,0,0,0,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid detect,0,1,0,0,0,1
covid icu containment measures,0,0,0,1,0,1
covid rehabilitation program for the elderly (core),0,0,1,0,0,1
covid vaccines,0,0,1,0,0,1
covid19 rt-pcr,0,1,0,0,0,1
covidseq test,0,0,1,0,0,1
covx,0,1,0,0,0,1
cries 13 questionnaire,0,0,0,1,0,1
cross-sectional genetics study,0,0,0,1,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross-sectional survey,1,0,0,0,0,1
cross sectional e-survey on surgeons exposed to any educational intervention,1,0,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
cube rapid test,1,0,0,0,0,1
current clinical practices of participating physicians,0,1,0,0,0,1
current health,0,0,0,1,0,1
cvncov,0,0,0,1,0,1
cycle threshold,0,0,0,1,0,1
cystatin c,0,0,0,1,0,1
cytokine hemadsorption,0,0,0,1,0,1
cytokines measurement,0,1,0,0,0,1
cytotoxic t lymphocytes,0,0,0,1,0,1
d region,0,0,0,1,0,1
daily syndromic surveillance,0,0,1,0,0,1
darunavir,0,0,0,1,0,1
darunavir/cobicistat,0,0,0,1,0,1
dass-21 instrument (depression,0,0,1,0,0,1
dass-21 instrument (depression/anxiety),0,0,1,0,0,1
dass questionnaire,0,1,0,0,0,1
data collecting,0,0,0,1,0,1
data collection (,0,0,0,1,0,1
data collection from blood draw,0,0,0,1,0,1
data collection from lumbar puncture,0,0,0,1,0,1
data collection from medical files,0,0,0,1,0,1
data collection up to 1 year,1,0,0,0,0,1
data collection: clinical care assessments,1,0,0,0,0,1
data monitoring for 48h within the first 24 hours of admission for covid-19,0,0,0,1,0,1
"data research, database analysis",0,1,0,0,0,1
death with routine,1,0,0,0,0,1
decisions of limitations,0,0,0,1,0,1
decisions of limitations/stop processing,0,0,0,1,0,1
demographic characteristics,0,1,0,0,0,1
depression assessment,0,0,0,1,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
derivatives,1,0,0,0,0,1
description of groups caracteristics,0,1,0,0,0,1
determination of sars-cov2 presence in cns,0,0,0,1,0,1
device used to record voice for screening,0,0,0,1,0,1
dexamethasone,0,1,0,0,0,1
dexamethasone oral,1,0,0,0,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,1,0,0,0,1
diagnostic examination for venous thromboembolism,0,1,0,0,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diagnostic test:blood test,0,0,0,1,0,1
diagnostic tests,0,0,0,1,0,1
diet tracking,1,0,0,0,0,1
"dietary counselling on food groups according to iyc feeding practices, who",1,0,0,0,0,1
dietary intervention,0,1,0,0,0,1
differences in triage,0,1,0,0,0,1
differential leucocyte count (cldc) device,1,0,0,0,0,1
differential leucocyte count (cldc) device/algorithm,1,0,0,0,0,1
diffusing capacity of carbon monoxide,0,0,1,0,0,1
digital storytelling intervention,0,1,0,0,0,1
dlco,0,0,0,1,0,1
doctor spot,0,1,0,0,0,1
dornase alfa,0,1,0,0,0,1
dry blood spot collection (euroimmun),0,0,0,1,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
"duration of hospitalization, mortality rate",0,1,0,0,0,1
during covid-19 pandemic,0,0,0,1,0,1
dysautonomia,0,0,0,1,0,1
dysphagia handicap index (dhi),0,0,0,1,0,1
early rehabilitation,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
easycov poc,0,0,0,1,0,1
eat-26 questionnaire,0,1,0,0,0,1
eating habits,0,0,0,1,0,1
ecg data analysis,0,1,0,0,0,1
ecg from handheld device,0,0,0,1,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
edinburgh postnatal depression scale,0,0,0,1,0,1
edinburgh postnatal depression scale (edps),0,0,0,1,0,1
education,0,1,0,0,0,1
education sessions,0,0,0,1,0,1
educational meetings/visual prompts,0,1,0,0,0,1
ei open ended pre-survey,0,0,1,0,0,1
ei open ended pre-survey/semi structured interview,0,0,1,0,0,1
"elecsys anti-sars-cov-2 s (roche diagnostics gmbh, mannheim, germany), 2) access sars-cov-2 igg ii (beckman coulter, inc. usa)",0,0,0,1,0,1
elecsys semi-quantitative anti-sars-cov-2 antibody test,0,1,0,0,0,1
elective cancer surgery,0,0,0,1,0,1
electrical impedance tomography,0,0,0,1,0,1
electro impedance tomography,0,0,0,1,0,1
electrocardiogram (ecg),0,0,0,1,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
"electrocardiography ,tomographic imaging",0,1,0,0,0,1
electrolytes,1,0,0,0,0,1
elispot,0,0,0,1,0,1
elispot: detection of the t cells specific to different sars-cov-2 proteins,0,0,0,1,0,1
emergency general surgical admissions,0,1,0,0,0,1
emergency laparotomy,0,1,0,0,0,1
emergent cases,0,1,0,0,0,1
encephalography measurement,0,0,0,1,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
endotracheal intubation,0,0,0,1,0,1
enoxaparin,0,0,0,1,0,1
environmental exposure,0,0,0,1,0,1
environmental exposure/clinical features,0,0,0,1,0,1
epds (edinburgh postnatal depression scale),0,1,0,0,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
equipment with smartwatch throughout hospital stay on the general ward,0,0,0,1,0,1
euroimmun assay,0,0,0,1,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
"evaluation of clinical, instrumental",0,0,0,1,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",0,0,0,1,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the degree of steatosis,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,1,0,0,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
experience of pandemic,0,0,0,1,0,1
experiences in close relationship scale questionnaire (ecr-s),0,0,0,1,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,0,0,1,0,1
experts consensus,0,1,0,0,0,1
exposure surveys,0,1,0,0,0,1
exposure to covid-19,0,0,0,1,0,1
exposure to covid19,0,0,0,1,0,1
exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
"exposure to telemedicine, after the onset of the pandemic",0,0,0,1,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
extended post anaesthetic care in pacu,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,1,0,0,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
famotidine,0,1,0,0,0,1
favorable outcome,0,1,0,0,0,1
feasibility of using the opal app for covid,0,1,0,0,0,1
fecal,0,1,0,0,0,1
fibreoptic endoscopic evaluation of swallowing (fees),0,0,0,1,0,1
fibrin generation markers assays,1,0,0,0,0,1
file inquiry,0,1,0,0,0,1
filling in an online survey,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
flavor test,0,1,0,0,0,1
flow cytometry: detection of the sars-cov-2 specific t-helpers,0,0,0,1,0,1
flow cytometry: detection of the sars-cov-2 specific t-helpers/cytotoxic t lymphocytes,0,0,0,1,0,1
flu shot,0,0,1,0,0,1
fmd,0,0,0,1,0,1
fmf.,0,0,1,0,0,1
follow-up of patients with covid-19,0,0,0,1,0,1
fondaparinux,0,1,0,0,0,1
fsfi survey,0,1,0,0,0,1
fulfilling questionaires,0,0,0,1,0,1
functional analysis,0,0,0,1,0,1
functional mri,0,0,0,1,0,1
fungal rhinosinusitis,0,1,0,0,0,1
further processing of health data,0,0,0,1,0,1
gad-7 (7-item generalized anxiety disorder),0,1,0,0,0,1
gad-7 (general anxiety disorder) scale,0,1,0,0,0,1
gad-7 (generalized anxiety disorder) scale (during containment),0,0,0,1,0,1
gad-7 (generalized anxiety disorder) scale (post containment),0,0,0,1,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gam-covid-vac,0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
gastric cancer surgery,0,1,0,0,0,1
general public cohort,0,1,0,0,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
generalized anxiety disorder-7 (gad 7),0,0,0,1,0,1
genetic,0,0,0,1,0,1
genetic analyses.,0,0,0,1,0,1
genetic analysis:,0,0,0,1,0,1
geneva emotional competence test (geco),0,0,1,0,0,1
global longitudinal strain,0,1,0,0,0,1
global survey,0,1,0,0,0,1
gloves,0,1,0,0,0,1
glucose control,0,1,0,0,0,1
glucose control/sensor usage,0,1,0,0,0,1
glycaemic levels,0,0,0,1,0,1
glycomic analysis,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,1,0,0,0,1
grandiosity subscales,0,1,0,0,0,1
group 1,1,0,0,0,0,1
group1,0,0,0,1,0,1
guduchi ghan vati,0,1,0,0,0,1
gustatory tests,0,1,0,0,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
health,0,1,0,0,0,1
health-related quality of life,0,0,0,1,0,1
health questionnaire,1,0,0,0,0,1
"health, daily self-assessment,",0,1,0,0,0,1
health/safety executive's (hse) management standards indicator tool (msit) to measure work-related stress,0,1,0,0,0,1
healthcare workers with the coronavac vaccine,0,1,0,0,0,1
heart-lung interactions,0,0,0,1,0,1
heparin,0,1,0,0,0,1
high-flow nasal cannula treatment,0,1,0,0,0,1
high flow nasal cannula,0,1,0,0,0,1
high peep with end inspiratory pause,0,0,0,1,0,1
high peep without end inspiratory pause,0,0,0,1,0,1
hip arthropalsty,0,1,0,0,0,1
hip fracture surgery,0,1,0,0,0,1
holter monitor,0,1,0,0,0,1
home-use test,0,0,0,1,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
home spirometry,0,0,0,1,0,1
hospital acquired infection,0,0,0,1,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety depression measure,0,0,0,1,0,1
hospital anxiety depression scale,0,1,0,0,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
hospitalisation for sars-cov2 infection,0,0,0,1,0,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",0,0,0,1,0,1
hospitalization,0,0,0,1,0,1
hospitalization for premature birth,0,0,1,0,0,1
hospitalized patients for covid-19 infection,0,1,0,0,0,1
host genotype,0,0,0,1,0,1
host immune factors,0,0,0,1,0,1
hr-ct-scan,0,0,0,1,0,1
hscore,1,0,0,0,0,1
human milk donors,0,0,0,1,0,1
humoral,0,0,1,0,0,1
humoral/cellular immunity,0,0,1,0,0,1
ice swimming,0,1,0,0,0,1
ier-r (posttraumatic stress),0,0,1,0,0,1
igg antibodies assay,0,0,0,1,0,1
igg detection,0,0,0,1,0,1
igg neutralising antibody titers to s1,0,0,0,1,0,1
igg neutralising antibody titers to s1/s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
igg sars cov 2 antibodies,0,1,0,0,0,1
igg sars cov2,0,1,0,0,0,1
igg test,0,1,0,0,0,1
"igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
igm test,0,0,1,0,0,1
igm/igg antibodies assay,0,0,0,1,0,1
imaging,0,0,0,1,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
"immune response monitoring , blood samples",0,0,0,1,0,1
immune response study,0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunoformulation,0,1,0,0,0,1
immunogenicity after first dose of participants who received first dose of chadox-1 n cov-19 vaccine,0,1,0,0,0,1
immunoglobulin,0,1,0,0,0,1
immunoglobulin g detection,0,0,0,1,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunological analysis:,0,0,0,1,0,1
immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),0,0,0,1,0,1
immunoseq,0,0,1,0,0,1
immunosuppressive,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impact of covid-19 questionnaire,0,0,0,1,0,1
in-hospital mortality rate,0,1,0,0,0,1
in-person instruction,1,0,0,0,0,1
inactivated covid-19 vaccine,0,0,0,1,0,1
incentive spirometer,0,0,0,1,0,1
incentive spirometer/respiratory exerciser,0,0,0,1,0,1
individual interview,0,1,0,0,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
inflammatory markers sampling,0,0,0,1,0,1
inflammatory parameters,0,1,0,0,0,1
infliximab,0,0,0,1,0,1
influenza rapid test,1,0,0,0,0,1
informational videos,0,0,0,1,0,1
informational videos/social media campaigns encouraging cancer screening.,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
instrumental examination,0,0,0,1,0,1
integrated clinical evaluation,0,1,0,0,0,1
intensive care,0,1,0,0,0,1
intensive care unit admission ratio,0,0,0,1,0,1
intensive care unit stay during the covid-19 pandemic,0,0,0,1,0,1
inter icu long distance patient transfer,0,0,0,1,0,1
interleuken 6,0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
interventions,0,0,0,1,0,1
intestinal microbiota,0,0,0,1,0,1
intestinal parasite,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
invasive mechanical ventilation,0,1,0,0,0,1
invasive ventilation strategy,0,0,0,1,0,1
investigation of smell,0,1,0,0,0,1
investigation of smell/taste disorders,0,1,0,0,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
iota carrageenan nasal spray,0,1,0,0,0,1
iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),0,1,0,0,0,1
ip-10,0,1,0,0,0,1
its,0,0,0,1,0,1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
ivermectin 6 mg oral tablet,0,1,0,0,0,1
ivermectin/deamethisone/aspirin,0,1,0,0,0,1
ivermectin/deamethisone/exoparin,0,1,0,0,0,1
jnj-78436735,0,0,0,1,0,1
kaletra,0,0,0,1,0,1
kaletra/beta interferon,0,0,0,1,0,1
kb109,0,0,0,1,0,1
kb109 / self supportive care,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kir phenotype evaluation,0,1,0,0,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
lab workup (on admission,0,0,0,1,0,1
lab workup (on admission/regularly during follow up).,0,0,0,1,0,1
laboratory,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory diagnostics tests,0,0,0,1,0,1
laboratory parameters,0,1,0,0,0,1
laboratory results,0,1,0,0,0,1
laboratory samples,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,0,0,1,0,0,1
laboratory tests,0,0,0,1,0,1
laboratory tests/montreal cognitive assessment,0,0,0,1,0,1
laboratory values,0,1,0,0,0,1
laboratory/instrumental examination,0,0,0,1,0,1
labs,0,0,0,1,0,1
lamp,0,1,0,0,0,1
laparoscopic,0,1,0,0,0,1
laparoscopic appendectomy,0,1,0,0,0,1
laparoscopic/open appendicectomy,0,1,0,0,0,1
lateral position (left,0,0,0,1,0,1
lateral position (left/right lateral decubitus),0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
liver,0,0,1,0,0,1
liver function tests,0,1,0,0,0,1
lmwh,0,1,0,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
loneliness,0,0,0,1,0,1
loneliness in the covid-19 environment.,0,0,0,1,0,1
longitudinally,0,0,0,1,0,1
lopinavir,0,0,0,1,0,1
lopinavir/ritonavir,0,0,0,1,0,1
low peep - fio2 high,0,0,0,1,0,1
low peep - fio2 low,0,0,0,1,0,1
lung biopsy,0,0,0,1,0,1
lung computed tomography,1,0,0,0,0,1
lung ct,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
machine learning classification of parenchymal lung change cause,0,0,0,1,0,1
machine learning classification of recurrence,0,0,0,1,0,1
machine learning classification of recurrence/non-recurrence,0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
magec spine rod,0,0,0,1,0,1
magnetic resonance imaging,0,0,0,1,0,1
mailer-based finger-prick,0,0,0,1,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
"masimo, lidco",0,0,0,1,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
"maternal attachment, edinburgh depression scoring",0,1,0,0,0,1
"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",0,1,0,0,0,1
maternal sars-cov-2 infection,0,0,0,1,0,1
maternal stress,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
measurement of circulating sflt1 concentration,0,1,0,0,0,1
measurement of concentration on exhaled carbon monoxide,0,0,0,1,0,1
measurement of respiratory muscle force,0,0,0,1,0,1
measurement of sublingual microcirculation,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
medical consultation,0,0,0,1,0,1
medical follow-up,0,0,0,1,0,1
medical records analysis,0,1,0,0,0,1
membrane-based immunoassay kit,0,0,0,1,0,1
mental health questionnaire,0,0,0,1,0,1
mental health student,0,1,0,0,0,1
mental well-being assessment,0,1,0,0,0,1
microcirculation recording,0,0,0,1,0,1
microscopy of defined brain regions on autopsy specimens,0,0,0,1,0,1
mindfulness training,0,0,0,1,0,1
mindrhythm harmony,0,0,0,1,0,1
minimal collection of products of the human body carried out during a sample for standard of care,0,0,0,1,0,1
mitral valve surgery,0,0,0,1,0,1
"ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
modafinil,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
modification,0,1,0,0,0,1
monitoring for aggravation,0,0,0,1,0,1
montelukast,0,1,0,0,0,1
month 12 after first symptoms from sars-cov-2 infection,0,0,0,1,0,1
montreal cognitive assessment,0,0,0,1,0,1
mortality,0,0,0,1,0,1
mr-pro-adm,0,1,0,0,0,1
"mri (heart, brain, lungs, liver)",0,0,0,1,0,1
mri scans,0,0,0,1,0,1
mrna-1273,0,0,0,1,0,1
mrna in urine test,0,1,0,0,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
multitest 6 color tbnk,0,1,0,0,0,1
multitest 6 color tbnk/bd lyotubes,0,1,0,0,0,1
muscle,1,0,0,0,0,1
musclesound ultrasound,0,0,0,1,0,1
n,0,0,0,1,0,1
n-binding igg immunoassays,0,0,0,1,0,1
n/a - samples collected along routine care samples only,0,0,0,1,0,1
na (no intervention),1,0,0,0,0,1
nasal high flow,0,1,0,0,0,1
naser al-husban,0,1,0,0,0,1
nasopharyngeal,0,1,0,0,0,1
nasopharyngeal (np) swab,0,0,0,1,0,1
nasopharyngeal samples,0,0,0,1,0,1
nasopharyngeal sampling,0,0,0,1,0,1
nasopharyngeal swab for sars-cov-2,1,0,0,0,0,1
nasopharyngeal/throat swab,0,1,0,0,0,1
nbi images and,0,0,0,1,0,1
nbi images and/or videos,0,0,0,1,0,1
ncapp,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
neuroimaging findings in patients with covid-19,0,1,0,0,0,1
neurological analysis,0,0,0,1,0,1
neuropsychological assessment,0,0,0,1,0,1
neuropsychological questionnaires,0,0,0,1,0,1
neuropsychometric test,1,0,0,0,0,1
newborns,0,1,0,0,0,1
news,0,1,0,0,0,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no active intervention (observational only),1,0,0,0,0,1
no intervention-mechanistic study,0,0,0,1,0,1
no intervention (survey study for medical doctors).,0,1,0,0,0,1
no intervention as it is an observational study,0,0,0,1,0,1
no intervention is planned,0,0,1,0,0,1
no intervention performed,0,1,0,0,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
no intervention used,0,0,0,1,0,1
"no intervention will be administered, this is a retrospective observational study.",0,0,0,1,0,1
"no intervention, observation only",0,0,0,1,0,1
"no intervention, questioner only",0,1,0,0,0,1
no intervention. method study. psychometric testing,0,0,0,1,0,1
no intervention; observational study,0,0,0,1,0,1
no interventional study,0,1,0,0,0,1
"no interventions performed. just collecting data, blood samples",0,0,0,1,0,1
"no interventions performed. just collecting data, blood samples/post-mortem biopsies.",0,0,0,1,0,1
no intervetion will be used,0,0,0,1,0,1
non-acei,0,1,0,0,0,1
non-acei/arb,0,1,0,0,0,1
non-cardiac surgery,0,0,0,1,0,1
non-invasive cardiac imaging,0,0,0,1,0,1
non-invasive ventilation strategies,0,0,0,1,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non-recurrence,0,0,0,1,0,1
non intervention,0,0,0,1,0,1
non invasive visual acuity testing,0,1,0,0,0,1
none - descriptive study,0,0,0,1,0,1
none - na,0,1,0,0,0,1
none - observational,0,1,0,0,0,1
"none, this study is observational",0,1,0,0,0,1
none. as this was an observational study.,0,1,0,0,0,1
noninvasive ventilation,0,1,0,0,0,1
noninvasive ventilation treatment,0,1,0,0,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not applicable (na),0,0,0,1,0,1
not applicable as observational study,1,0,0,0,0,1
"not applicable, this is an observational study",1,0,0,0,0,1
not required,0,1,0,0,0,1
nps test,0,0,0,1,0,1
nricm101,0,0,0,1,0,1
"nursing care to reduce anxiety, fear",0,0,0,1,0,1
"nursing care to reduce anxiety, fear/loneliness",0,0,0,1,0,1
nutrition,1,0,0,0,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
nvx-cov2373,0,0,0,1,0,1
observation for study group,1,0,0,0,0,1
observation group 1,0,1,0,0,0,1
observation of breathing pattern,0,1,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute),0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute)/settings,0,0,0,1,0,1
observation to monitor patients for these infections,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,0,0,0,1,0,1
observational measurement of biometric data. no change to health care provided.,0,1,0,0,0,1
observational study - no intervention,0,0,0,1,0,1
observational study exploring the epidemiology,1,0,0,0,0,1
observational study exploring the epidemiology/outcomes of aki in critical covid-19 patients admitted to the icu,1,0,0,0,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
occupational health workers,0,0,0,1,0,1
odd,0,1,0,0,0,1
odd/even birth year intervention groups,0,1,0,0,0,1
ofatumumab,0,0,0,1,0,1
olfaction testing,0,0,0,1,0,1
olfactory,0,1,0,0,0,1
olfactory device,0,1,0,0,0,1
olfactory function evaluation,0,1,0,0,0,1
olfactory/gustatory tests,0,1,0,0,0,1
online instruction,1,0,0,0,0,1
online survey questionnaire,0,0,0,1,0,1
opaganib,0,1,0,0,0,1
open appendicectomy,0,1,0,0,0,1
optical coherence tomography angiography,0,1,0,0,0,1
optional interview,0,0,0,1,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
or mis-c exposure,0,0,0,1,0,1
or videos,0,0,0,1,0,1
oropharyngeal,0,0,0,1,0,1
oropharyngeal swabs,0,1,0,0,0,1
oropharyngeal/intestinal microbiota,0,0,0,1,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
osteosynthesis,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
outcomes of aki in critical covid-19 patients admitted to the icu,1,0,0,0,0,1
outpatient clinic,0,0,0,1,0,1
overnight intensive recovery,0,0,0,1,0,1
overnight intensive recovery / extended post anaesthetic care in pacu,0,0,0,1,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
pain,0,0,0,1,0,1
pain/neuropsychological questionnaires,0,0,0,1,0,1
pandemic control measures,0,0,0,1,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
patient characteristics,0,1,0,0,0,1
patient health questionnaire (phq-9),0,0,0,1,0,1
patient quality of life assessment,0,1,0,0,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,1,0,0,0,0,1
patients admitted in intensive care units,0,0,0,1,0,1
patients admitted to intensive care unit with sars-cov2,0,1,0,0,0,1
patients received standard of care treatment during hospitalization,0,0,0,1,0,1
pcr value,0,0,0,1,0,1
pcr/chest ct,0,1,0,0,0,1
pcr/serology,0,0,0,1,0,1
pct,0,0,0,1,0,1
pct/serology,1,0,0,0,0,1
peep,0,0,0,1,0,1
peer support,0,0,1,0,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
percutaneous treatment,0,0,0,1,0,1
performing ai algorithms on images,0,0,0,1,0,1
peripheral blood samples,0,0,0,1,0,1
peripheral lymphocytes subsets,0,0,0,1,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective testing booth,0,1,0,0,0,1
personalized ambulatory training,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
pharyngeal swab,1,0,0,0,0,1
philips lumify ultrasound system,0,1,0,0,0,1
phlebotomy,0,0,0,1,0,1
phobia questionairre,0,0,0,1,0,1
phone interview,0,0,0,1,0,1
phone interviews,0,0,0,1,0,1
phq,0,1,0,0,0,1
phq-9 depression scale,0,0,0,1,0,1
phsyiotherapy,1,0,0,0,0,1
physical activity level,0,0,0,1,0,1
physical activity program,0,0,0,1,0,1
physical examination,0,0,0,1,0,1
physiotherapy,0,1,0,0,0,1
pilot a rapid sars-cov-2 testing strategy,0,1,0,0,0,1
plasma igg levels,0,0,0,1,0,1
plasma sampling,0,0,0,1,0,1
"platelet count, platelet, mean platelet volume",0,0,0,1,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,0,0,1,0,1
platelet distribution width in covid-19,0,0,0,1,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
poc sars-cov-2 igg antibody test,0,1,0,0,0,1
poct,1,0,0,0,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech),0,0,0,1,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech)/dry blood spot collection (euroimmun),0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",0,0,0,1,0,1
polymerase chain reaction (pcr) test,1,0,0,0,0,1
polyoxidonium,0,1,0,0,0,1
polysomnography,1,0,0,0,0,1
pool lamp,0,1,0,0,0,1
pool rt-pcr,0,1,0,0,0,1
positive for sars-cov-2 infection,0,0,0,1,0,1
post-intensive care unit syndrome,0,0,0,1,0,1
post-mortem biopsies.,0,0,0,1,0,1
post-traumatic stress screening,0,0,0,1,0,1
post covid-19 functional satus scale,0,0,0,1,0,1
post traumatic stress disorder questionnaire (ptsd-8),0,0,0,1,0,1
postpartum anxiety scale scores,0,1,0,0,0,1
pre-operative screening,0,0,0,1,0,1
pre-pandemic stroke related metrics,0,0,0,1,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
prevalence of covid-19,0,1,0,0,0,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
primary exposure status of pfizer-biontech covid-19 vaccine,1,0,0,0,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
prognostic score,1,0,0,0,0,1
prone lying position,0,1,0,0,0,1
prone position on ecmo patient,0,1,0,0,0,1
proper diet,0,0,0,1,0,1
prospective chart review,0,1,0,0,0,1
prospective cohort in high body mass index patient with covid 19,0,1,0,0,0,1
prospective oberservational registry,0,0,0,1,0,1
prospective observation,0,0,0,1,0,1
proteinuria,0,1,0,0,0,1
psqi,0,1,0,0,0,1
pss,0,1,0,0,0,1
psychological,0,1,0,0,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological/sociological interviews,0,1,0,0,0,1
psychometric scale administration,0,0,0,1,0,1
ptsd,0,0,0,1,0,1
ptsd check list (pcl) scale,0,0,0,1,0,1
public health england gold standard,0,0,0,1,0,1
pulmonary function test,0,0,0,1,0,1
pulse oximeter,0,0,0,1,0,1
pwv,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
qualitative analysis for professionals,0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
qualitative interviews..,0,0,0,1,0,1
quality of life diagnosis,0,0,1,0,0,1
quality of life diagnosis/therapy during the completed rct diqol,0,0,1,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,1,0,0,0,1
quantiferon,0,0,0,1,0,1
quantitative,0,0,0,1,0,1
quantitative analysis for patients,0,0,0,1,0,1
quantitative analysis for professionals,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative analysis of sars-cov-2 antibodies,0,1,0,0,0,1
quantitative antibody tests,0,0,0,1,0,1
quantitative sensory testing,0,0,0,1,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
quasistatic pressure-volume curve,0,0,0,1,0,1
querying the insee database,0,0,0,1,0,1
questionaire,0,1,0,0,0,1
questionnaire : preparedness for caregiving scale,0,0,0,1,0,1
questionnaire about impact of the covid-19 pandemic on orthopaedic resident training,0,1,0,0,0,1
"questionnaire administration,blood sampling",0,0,0,1,0,1
"questionnaire administration,blood sampling/genetic analyses.",0,0,0,1,0,1
questionnaire study (cross-sectional analytical clinical research),0,0,1,0,0,1
questionnaire survey,0,1,0,0,0,1
"questionnaire, phone call",0,0,0,1,0,1
questionnaire/interview,0,1,0,0,0,1
questionnaire/optional interview,0,0,0,1,0,1
questionnaires covid,0,0,0,1,0,1
questionnaires covid-,0,0,0,1,0,1
questionnaires covid/,0,0,0,1,0,1
questionnaires on psychological quality of life,0,1,0,0,0,1
questionnaires/neuropsychological assessment,0,0,0,1,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
quidel quickvue antigen test for covid-19,0,0,0,1,0,1
radiological,0,0,0,1,0,1
radiological lung involvement evolution,0,0,0,1,0,1
radiological variables?,1,0,0,0,0,1
radiotherapy,0,1,0,0,0,1
rapid-3,0,0,1,0,0,1
rapid antibody test,0,0,0,1,0,1
rapid antigen test (panbio ag test),0,0,0,1,0,1
rapid antigen test for sars cov2,0,1,0,0,0,1
rapid antigen testing versus rt-pcr,0,1,0,0,0,1
rapid molecular test,0,0,0,1,0,1
rarefaction,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
recently vaccination,0,0,0,1,0,1
recombinase,0,0,0,1,0,1
recommended treatment schedule,0,0,0,1,0,1
recording of hemodynamic monitoring,1,0,0,0,0,1
recording of respiratory monitoring,1,0,0,0,0,1
recordings of cough sounds from adults,0,0,0,1,0,1
regularly during follow up).,0,0,0,1,0,1
rehabilitation,0,0,0,1,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
relationship scales questionnaire (rsq),0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
repeat sars-cov-2 igg antibodies at 45-65 days,0,1,0,0,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
research specific blood sample,0,0,0,1,0,1
respiratory exerciser,0,0,0,1,0,1
respiratory functions,0,1,0,0,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitor,0,0,0,1,0,1
respiratory monitoring,0,0,0,1,0,1
respiratory muscles ultrasound,0,0,0,1,0,1
respiratory physiotherapy,0,1,0,0,0,1
respiratory rehabilitation,0,0,0,1,0,1
respiratory supports,0,1,0,0,0,1
respiratory swabs,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
respiratory systems monitoring,0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective data,0,0,0,1,0,1
retrospective data/biological samples,0,0,0,1,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
review of medical file,0,0,0,1,0,1
review of medical patient file,0,1,0,0,0,1
reviewed clinical records,0,1,0,0,0,1
reviewed clinical records/laboratory results,0,1,0,0,0,1
right lateral decubitus),0,0,0,1,0,1
risk factors,0,1,0,0,0,1
ritonavir,0,0,0,1,0,1
rivaroxaban,0,0,0,1,0,1
routine dental restorative procedures,0,0,0,1,0,1
rt-pcr for sars-cov-2,0,0,0,1,0,1
"s-binding igg, rbd-binding igg",0,0,0,1,0,1
"s-binding igg, rbd-binding igg/n-binding igg immunoassays/sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",0,0,0,1,0,1
s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
safety executive's (hse) management standards indicator tool (msit) to measure work-related stress,0,1,0,0,0,1
saint george respiratory questionnaire,0,0,1,0,0,1
saliva based assay: crude rna extraction,0,0,0,1,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
samba ii,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 and,0,0,0,1,0,1
sars-cov-2 and/or mis-c exposure,0,0,0,1,0,1
sars-cov-2 antibody analysis,0,0,1,0,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 igg,0,0,0,1,0,1
sars-cov-2 mrna vaccine,1,0,0,0,0,1
sars-cov-2 pcr/serology tests,0,1,0,0,0,1
sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,1,0,0,0,0,1
"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
sars-cov-2 s1,0,1,0,0,0,1
sars-cov-2 s1/s2 igg,0,1,0,0,0,1
sars-cov-2 serology,0,0,0,1,0,1
"sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",0,0,0,1,0,1
sars-cov-2 specific igm,0,0,0,1,0,1
sars-cov-2 specific igm/igg detection,0,0,0,1,0,1
sars-cov-2 vaccine,0,0,0,1,0,1
"sars-cov-2 vaccine(vero cell), inactivated",0,0,0,1,0,1
sars-cov-2 virus vaccines,0,0,0,1,0,1
sars-cov2 antibody measurement,0,0,0,1,0,1
sars-cov2 infection,0,0,0,1,0,1
sars - cov 2 vaccine,0,0,0,1,0,1
sars cov-2 swabs,1,0,0,0,0,1
satisfaction evaluation,0,1,0,0,0,1
scales,0,0,0,1,0,1
scales.,0,1,0,0,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
screening for the components of metabolic syndrome,0,0,0,1,0,1
sedation,0,0,0,1,0,1
"selenium, zinc",0,1,0,0,0,1
"selenium, zinc/copper, vitamin a, d, e plasma concentrations during patient hospitalization",0,1,0,0,0,1
self-administered questionnaire,0,1,0,0,0,1
self-assesment questionnaire,0,1,0,0,0,1
self-reported symptom collection,0,1,0,0,0,1
self supportive care,0,0,0,1,0,1
self supportive care (ssc) alone,0,0,0,1,0,1
semen qualitative analysis,1,0,0,0,0,1
semi-directed entretien,0,0,0,1,0,1
semi-structured telephone questionnaire,0,0,0,1,0,1
semi structured interview,0,0,1,0,0,1
sending thorax ct video images via smartphone applications,0,1,0,0,0,1
sensor usage,0,1,0,0,0,1
separic-covid19 cohort,0,1,0,0,0,1
sequencing,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serodiagnosis of igg,0,0,0,1,0,1
serodiagnosis of igg/igm,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immune response evaluation,0,0,0,1,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
serologic test,0,0,0,1,0,1
serological assay for sars-cov-2,0,0,0,1,0,1
serological covid-19 vaccine immunogenicity,0,0,0,1,0,1
serological surveillance,0,0,0,1,0,1
serology test for covid-19,0,0,0,1,0,1
"serology testing, rt pcr",0,0,0,1,0,1
serology tests,0,1,0,0,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
"serum collection, adverse events collection",0,0,0,1,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,1,0,0,0,1
serum ngal,0,0,0,1,0,1
serum ngal/cystatin c,0,0,0,1,0,1
serum protein level analysis,0,1,0,0,0,1
service of questionnaire,0,1,0,0,0,1
settings,0,0,0,1,0,1
severe acute respiratory syndrome coronavirus 2 detection,0,1,0,0,0,1
sex hormones,0,1,0,0,0,1
sg diagnostics covid-19 antigen rapid test kit,1,0,0,0,0,1
simple chest tomography,0,1,0,0,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
single-nucleotide polymorphisms (snp) within the tcra,0,0,0,1,0,1
single-nucleotide polymorphisms (snp) within the tcra/d region,0,0,0,1,0,1
sinopharm,0,0,0,1,0,1
sivomixx,1,0,0,0,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
six minutes walk test,0,0,0,1,0,1
smartphone-based voice,0,1,0,0,0,1
smartphone-based voice/self-reported symptom collection,0,1,0,0,0,1
smartphone technology,1,0,0,0,0,1
social distancing,0,1,0,0,0,1
social media,0,1,0,0,0,1
social media campaigns encouraging cancer screening.,0,0,0,1,0,1
social media/news consumption,0,1,0,0,0,1
sociodemographic,0,1,0,0,0,1
"sociodemographic/health, daily self-assessment,/feasibility of using the opal app for covid",0,1,0,0,0,1
soluble urokinase plasminogen activator receptor,0,1,0,0,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
SOP,0,0,0,1,0,1
soton hyperinflammation score,1,0,0,0,0,1
spartan covid-19 test,0,0,0,1,0,1
spartan covid-19 v2 system,0,0,0,1,0,1
specific anti-sars-cov-2 antibodies,0,1,0,0,0,1
specific antibody,0,0,0,1,0,1
specific antibody/cellular immune response after anti-sars-cov-2 vaccine administration,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,1,0,0,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,1,0,0,0,1
sperm collection,0,0,0,1,0,1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",0,0,1,0,0,1
sputnik v,1,0,0,0,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
standard of health care,0,0,0,1,0,1
state-trait anxiety inventory scale,0,0,0,1,0,1
stc-19,0,1,0,0,0,1
stepped-care model,0,0,0,1,0,1
stop processing,0,0,0,1,0,1
stress,0,0,0,1,0,1
stress levels,0,1,0,0,0,1
stress levels/mental well-being assessment,0,1,0,0,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
stroke related metrics during the pandemic,0,0,0,1,0,1
study a,0,0,0,1,0,1
study arm,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
study questionnaire,0,0,0,1,0,1
subacute rehabilitation,0,0,0,1,0,1
"supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase",1,0,0,0,0,1
surfactant,1,0,0,0,0,1
surge capacity,0,1,0,0,0,1
surge index,0,1,0,0,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical procedure for cancer,0,0,0,1,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
surgical repair,0,0,0,1,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,0,0,1,0,1
suspected of covid-19 infection,0,0,0,1,0,1
swab,0,0,0,1,0,1
swabbing of conjunctiva,0,1,0,0,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
symptom,0,1,0,0,0,1
symptom/exposure surveys,0,1,0,0,0,1
symptoms,0,0,0,1,0,1
systemic,0,0,0,1,0,1
t-detect covid t-cell blood test,0,1,0,0,0,1
taste/olfactory function evaluation,0,1,0,0,0,1
tcm,0,1,0,0,0,1
tears swab,0,1,0,0,0,1
tele-pulmonary rehabilitation,0,0,0,1,0,1
telecare group,0,0,0,1,0,1
teleconsultation either by phone,0,1,0,0,0,1
teleconsultation either by phone/by computer consultation,0,1,0,0,0,1
telephone consult,0,0,0,1,0,1
tem-tpa,0,1,0,0,0,1
testing for sars-cov-2,0,1,0,0,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
testing with medical detection dogs,0,0,0,1,0,1
testnpass,0,0,0,1,0,1
th17 cytokine profile,0,0,0,1,0,1
"the demographic, clinical, laboratory,",0,1,0,0,0,1
"the demographic, clinical, laboratory,/instrumental data",0,1,0,0,0,1
the effects of covid 19 pandemic on the cardiovascular heath of children with autism spectrum disorder,1,0,0,0,0,1
the icp monitoring will be performed in a non-invasive method developed by brain4care,0,0,0,1,0,1
the placenta,0,1,0,0,0,1
"the study evaluates all surgical patients operated, both elective scheduled",0,1,0,0,0,1
"the study evaluates all surgical patients operated, both elective scheduled/emergent cases",0,1,0,0,0,1
therapy during the completed rct diqol,0,0,1,0,0,1
there is no intervention in this study,0,0,0,1,0,1
thoracic computed tomography scan,0,0,1,0,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,1,0,0,0,1
thorax ct,0,0,0,1,0,1
thoraxic computed tomography,0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,0,0,1,0,1
thrombin,1,0,0,0,0,1
thromboprophylaxis,0,1,0,0,0,1
thyroidectomy,0,1,0,0,0,1
titanium blood test,0,0,0,1,0,1
tlrs activation measurement,0,1,0,0,0,1
to determine the prevalence of renal dysfunction in hospitalized children with covid19 in qatar.,0,0,0,1,0,1
tobacco use,1,0,0,0,0,1
tof protocol,0,1,0,0,0,1
tomography angiography,0,1,0,0,0,1
tools development,0,0,0,1,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
traditional chinese medicine,0,0,0,1,0,1
training load,1,0,0,0,0,1
"training video on anxiety, fear",0,0,0,1,0,1
"training video on anxiety, fear/loneliness in the covid-19 environment.",0,0,0,1,0,1
transparent sheet,0,1,0,0,0,1
transplant patient,0,1,0,0,0,1
transpulmonary thermodilution,0,1,0,0,0,1
treatment data collect,0,1,0,0,0,1
treatment for covid-19,0,0,0,1,0,1
treatment group,0,1,0,0,0,1
trier social stress test,0,0,0,1,0,1
tuberculin,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
type ii diabetes mellitus,0,0,0,1,0,1
type ii diabetes mellitus/covid-19 group (group ii),0,0,0,1,0,1
use,0,1,0,0,0,1
use of continuous positive airway pressure,0,1,0,0,0,1
use of high flow nasal cannula alone,0,1,0,0,0,1
use of non-invasive ventilation,0,1,0,0,0,1
use of social media during covid-19,0,1,0,0,0,1
"use of the pinpointiq solution (physiq, inc.)",0,0,1,0,0,1
use/exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
v,0,0,0,1,0,1
v/q spect-ct,0,0,0,1,0,1
vaccine anti-covid19,0,0,0,1,0,1
vaccine coverage assessment,0,0,0,1,0,1
vaccine inoculation against sars-cov-2,0,0,0,1,0,1
validation of the lamp assays,0,0,0,1,0,1
validation of the ngs method,0,0,0,1,0,1
validation of the poct antigen,0,0,0,1,0,1
validation of the poct antigen/antibody tests,0,0,0,1,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
venous blood collection,0,0,0,1,0,1
venous blood was collected for biochemistry testing,0,1,0,0,0,1
venous blood was collected for biochemistry testing.,0,1,0,0,0,1
video call,0,1,0,0,0,1
video calls,0,1,0,0,0,1
videofluoroscopic swallowing study (vfss),0,0,1,0,0,1
videofluoroscopy,0,0,0,1,0,1
views,0,0,0,1,0,1
viral sequence,0,0,0,1,0,1
visual analogue scale,0,0,0,1,0,1
visual prompts,0,1,0,0,0,1
vitamin c,0,1,0,0,0,1
voice symptom scale (voiss),0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vv-ecmo,0,1,0,0,0,1
walk test,0,0,0,1,0,1
"wearable devices, saliva samples, survey measures",1,0,0,0,0,1
wearable medical device (empatica e4),0,0,0,1,0,1
web-based survey,1,0,0,0,0,1
web based questionnaire,0,0,1,0,0,1
weck-cel swab collection,0,0,1,0,0,1
well-being assessment,0,1,0,0,0,1
whoqol-bref,0,0,1,0,0,1
without colchicine,0,1,0,0,0,1
x-ray,0,0,0,1,0,1
yoga,0,0,0,1,0,1
zaritt burden interview,0,1,0,0,0,1
